These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 16974106)

  • 61. Thyroid hormone cell membrane transport defect.
    Ramos HE
    Endocr Dev; 2014; 26():108-17. PubMed ID: 25231447
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Expression of thyroid hormone transporters during critical illness.
    Mebis L; Paletta D; Debaveye Y; Ellger B; Langouche L; D'Hoore A; Darras VM; Visser TJ; Van den Berghe G
    Eur J Endocrinol; 2009 Aug; 161(2):243-50. PubMed ID: 19439506
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Pregnancy in women heterozygous for MCT8 mutations: risk of maternal hypothyroxinemia and fetal care.
    Ramos HE; Morandini M; Carré A; Tron E; Floch C; Mandelbrot L; Neri N; De Sarcus B; Simon A; Bonnefont JP; Amiel J; Desguerre I; Valayannopoulos V; Castanet M; Polak M
    Eur J Endocrinol; 2011 Feb; 164(2):309-14. PubMed ID: 21098685
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Sobetirome and its Amide Prodrug Sob-AM2 Exert Thyromimetic Actions in Mct8-Deficient Brain.
    Bárez-López S; Hartley MD; Grijota-Martínez C; Scanlan TS; Guadaño-Ferraz A
    Thyroid; 2018 Sep; 28(9):1211-1220. PubMed ID: 29845892
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Mct8-deficient mice have increased energy expenditure and reduced fat mass that is abrogated by normalization of serum T3 levels.
    Di Cosmo C; Liao XH; Ye H; Ferrara AM; Weiss RE; Refetoff S; Dumitrescu AM
    Endocrinology; 2013 Dec; 154(12):4885-95. PubMed ID: 24029243
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Relevance of different cellular models in determining the effects of mutations on SLC16A2/MCT8 thyroid hormone transporter function and genotype-phenotype correlation.
    Capri Y; Friesema EC; Kersseboom S; Touraine R; Monnier A; Eymard-Pierre E; Des Portes V; De Michele G; Brady AF; Boespflug-Tanguy O; Visser TJ; Vaurs-Barriere C
    Hum Mutat; 2013 Jul; 34(7):1018-25. PubMed ID: 23568789
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Central Hypothyroidism Impairs Heart Rate Stability and Prevents Thyroid Hormone-Induced Cardiac Hypertrophy and Pyrexia.
    Herrmann B; Harder L; Oelkrug R; Chen J; Gachkar S; Nock S; Resch J; Korkowski M; Heuer H; Mittag J
    Thyroid; 2020 Aug; 30(8):1205-1216. PubMed ID: 32188347
    [No Abstract]   [Full Text] [Related]  

  • 68. The MCT8 thyroid hormone transporter and Allan-Herndon-Dudley syndrome.
    Schwartz CE; Stevenson RE
    Best Pract Res Clin Endocrinol Metab; 2007 Jun; 21(2):307-21. PubMed ID: 17574010
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Long-Term Efficacy of T3 Analogue Triac in Children and Adults With MCT8 Deficiency: A Real-Life Retrospective Cohort Study.
    van Geest FS; Groeneweg S; van den Akker ELT; Bacos I; Barca D; van den Berg SAA; Bertini E; Brunner D; Brunetti-Pierri N; Cappa M; Cappuccio G; Chatterjee K; Chesover AD; Christian P; Coutant R; Craiu D; Crock P; Dewey C; Dica A; Dimitri P; Dubey R; Enderli A; Fairchild J; Gallichan J; Garibaldi LR; George B; Hackenberg A; Heinrich B; Huynh T; Kłosowska A; Lawson-Yuen A; Linder-Lucht M; Lyons G; Monti Lora F; Moran C; Müller KE; Paone L; Paul PG; Polak M; Porta F; Reinauer C; de Rijke YB; Seckold R; Menevşe TS; Simm P; Simon A; Spada M; Stoupa A; Szeifert L; Tonduti D; van Toor H; Turan S; Vanderniet J; de Waart M; van der Wal R; van der Walt A; van Wermeskerken AM; Wierzba J; Zibordi F; Zung A; Peeters RP; Visser WE
    J Clin Endocrinol Metab; 2022 Feb; 107(3):e1136-e1147. PubMed ID: 34679181
    [TBL] [Abstract][Full Text] [Related]  

  • 70. A child with a deletion in the monocarboxylate transporter 8 gene: 7-year follow-up and effects of thyroid hormone treatment.
    Zung A; Visser TJ; Uitterlinden AG; Rivadeneira F; Friesema EC
    Eur J Endocrinol; 2011 Nov; 165(5):823-30. PubMed ID: 21896621
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Intracerebroventricular High Doses of 3,3',5-Triiodothyroacetic Acid at Juvenile Stages Improve Peripheral Hyperthyroidism and Mediate Thyromimetic Effects in Limited Brain Regions in a Mouse Model of Monocarboxylate Transporter 8 Deficiency.
    Grijota-Martínez C; Montero-Pedrazuela A; Hidalgo-Álvarez J; Bárez-López S; Guadaño-Ferraz A
    Thyroid; 2023 Apr; 33(4):501-510. PubMed ID: 36565029
    [No Abstract]   [Full Text] [Related]  

  • 72. Changes in thyroid hormone activity disrupt photomotor behavior of larval zebrafish.
    Walter KM; Miller GW; Chen X; Harvey DJ; Puschner B; Lein PJ
    Neurotoxicology; 2019 Sep; 74():47-57. PubMed ID: 31121238
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Differential regulation of monocarboxylate transporter 8 expression in thyroid cancer and hyperthyroidism.
    Badziong J; Ting S; Synoracki S; Tiedje V; Brix K; Brabant G; Moeller LC; Schmid KW; Fuhrer D; Zwanziger D
    Eur J Endocrinol; 2017 Sep; 177(3):243-250. PubMed ID: 28576880
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Ablation of TRalpha2 and a concomitant overexpression of alpha1 yields a mixed hypo- and hyperthyroid phenotype in mice.
    Saltó C; Kindblom JM; Johansson C; Wang Z; Gullberg H; Nordström K; Mansén A; Ohlsson C; Thorén P; Forrest D; Vennström B
    Mol Endocrinol; 2001 Dec; 15(12):2115-28. PubMed ID: 11731613
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Placenta passage of the thyroid hormone analog DITPA to male wild-type and Mct8-deficient mice.
    Ferrara AM; Liao XH; Gil-Ibáñez P; Bernal J; Weiss RE; Dumitrescu AM; Refetoff S
    Endocrinology; 2014 Oct; 155(10):4088-93. PubMed ID: 25051435
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Genotype-phenotype relationship in patients with mutations in thyroid hormone transporter MCT8.
    Jansen J; Friesema EC; Kester MH; Schwartz CE; Visser TJ
    Endocrinology; 2008 May; 149(5):2184-90. PubMed ID: 18187543
    [TBL] [Abstract][Full Text] [Related]  

  • 77. X-linked paroxysmal dyskinesia and severe global retardation caused by defective MCT8 gene.
    Brockmann K; Dumitrescu AM; Best TT; Hanefeld F; Refetoff S
    J Neurol; 2005 Jun; 252(6):663-6. PubMed ID: 15834651
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Effects of Chemical Chaperones on Thyroid Hormone Transport by MCT8 Mutants in Patient-Derived Fibroblasts.
    Groeneweg S; van den Berge A; Meima ME; Peeters RP; Visser TJ; Visser WE
    Endocrinology; 2018 Mar; 159(3):1290-1302. PubMed ID: 29309566
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Intracerebroventricular administration of the thyroid hormone analog TRIAC increases its brain content in the absence of MCT8.
    Bárez-López S; Grijota-Martínez C; Liao XH; Refetoff S; Guadaño-Ferraz A
    PLoS One; 2019; 14(12):e0226017. PubMed ID: 31809508
    [TBL] [Abstract][Full Text] [Related]  

  • 80. MCT8 deficiency: extrapyramidal symptoms and delayed myelination as prominent features.
    Tonduti D; Vanderver A; Berardinelli A; Schmidt JL; Collins CD; Novara F; Genni AD; Mita A; Triulzi F; Brunstrom-Hernandez JE; Zuffardi O; Balottin U; Orcesi S
    J Child Neurol; 2013 Jun; 28(6):795-800. PubMed ID: 22805248
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.